{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:21Z","timestamp":1786480221992,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    Iodinated contrast media have long been feared for causing contrast-induced AKI (CI-AKI), a concern rooted in early reports with high-osmolar agents. Experimental data suggest potential nephrotoxic mechanisms, yet clinical evidence from older uncontrolled studies was confounded by comorbidities and procedural risks. Contemporary propensity-matched and controlled analyses consistently show that modern low-osmolar and isoosmolar contrast agents (mostly intravenously administered) uncommonly cause true nephrotoxicity, even among high-risk populations, such as patients with advanced CKD, AKI, or critical illness. Large randomized trials, including the Prevention of Serious Adverse Events Following Angiography trial, found no difference in outcomes between sodium bicarbonate and isotonic saline hydration as preventive strategies, nor\n                    <jats:italic toggle=\"yes\">N<\/jats:italic>\n                    -acetylcysteine administration, and highlighted risks like fluid overload. Persistent fear of CI-AKI has fueled renalism: unnecessary avoidance or delay of essential imaging, leading to worse outcomes. Current consensus emphasizes individualized care\u2014avoiding hypovolemia, limiting contrast dose, and withholding nephrotoxins only in severe kidney impairment. A balanced, evidence-based approach should replace outdated caution. For decades, clinicians have approached iodinated contrast media with excessive caution over CI-AKI. This concern originated in the mid-20th century when a seminal 1954 case report described acute renal failure in a patient with myeloma after injection of a high-osmolar contrast agent. Early contrast formulations indeed had nephrotoxic effects\n                    <jats:italic toggle=\"yes\">via<\/jats:italic>\n                    intense renal vasoconstriction, osmotic diuresis, and direct tubular injury. By the 1980s, any AKI after contrast exposure was broadly labeled CI-AKI, typically defined by a postprocedure increase in serum creatinine (&gt;0.5 mg\/dl or &gt;25%) in the absence of other causes. Transition to safer low-osmolar and isoosmolar agents in the late 1980s appears to have been a pivotal step, with other factors likely contributing to the temporal decline in CI-AKI incidence. These include refinement of AKI definitions, improvements in preventive measures (avoiding hypovolemia and suspension of nephrotoxic medications), reduction in the amount of injected contrast, more cautious patient selection, and overall improvements in the management of the underlying conditions for which contrast is administered (\n                    <jats:italic toggle=\"yes\">e.g<\/jats:italic>\n                    ., acute coronary syndromes and surgical and perioperative care). Nevertheless, the historical fear of CI-AKI has persisted, often disproportionate to modern evidence, sometimes leading to avoidance of necessary diagnostic imaging. This perspective reexamines the nephrotoxicity debate in light of current knowledge, aiming to replace outdated dogma with a balanced, evidence-based approach that prioritizes patient outcomes over unfounded fears.\n                  <\/jats:p>","DOI":"10.34067\/kid.0000001019","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:00:08Z","timestamp":1759424408000},"page":"445-449","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Time To Inject Some Contrast into the Nephrotoxicity Debate"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0960-6055","authenticated-orcid":false,"given":"Nans","family":"Florens","sequence":"first","affiliation":[{"name":"Nephrology, Dialysis and Transplantation Department, Strasbourg University Hospitals, 1 place de l\u2019H\u00f4pital, Strasbourg, France"},{"name":"Laboratoire d\u2019ImmunoRhumatologie Mol\u00e9culaire, INSERM UMR_S1109, F\u00e9d\u00e9ration Hospitalo-Universitaire TARGET, Groupe INTERFERENCE, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Institut Th\u00e9matique Interdisciplinaire (ITI) de M\u00e9decine de Pr\u00e9cision de Strasbourg, Universit\u00e9 de Strasbourg, Strasbourg, France"},{"name":"INI-CRCT, F-CRIN, Vandoeuvre-les-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7255-1114","authenticated-orcid":false,"given":"Julien","family":"Demiselle","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine. F\u00e9d\u00e9ration Hospitalo-Universitaire TARGET, Groupe INTERFERENCE. H\u00f4pitaux universitaires de Strasbourg, Service de M\u00e9decine Intensive-R\u00e9animation, Nouvel H\u00f4pital Civil, Universit\u00e9 de Strasbourg (UNISTRA), Strasbourg, France"},{"name":"INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"4","key":"B1-20260226","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.0954-6820.1954.tb18632.x","article-title":"Acute anuria following intravenous pyelography in a patient with myelomatosis","volume":"150","author":"Bartels","year":"1954","journal-title":"Acta Med Scand."},{"issue":"1","key":"B2-20260226","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12882-024-03570-6","article-title":"Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment","volume":"25","author":"Li","year":"2024","journal-title":"BMC Nephrol."},{"issue":"2","key":"B3-20260226","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0022-5193(69)80047-0","article-title":"Contrast agent design some aspects on the synthesis of water soluble contrast agents of low osmolality","volume":"24","author":"Almen","year":"1969","journal-title":"J Theor Biol."},{"issue":"9","key":"B4-20260226","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/RLI.0b013e318258502b","article-title":"The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety","volume":"47","author":"Lenhard","year":"2012","journal-title":"Invest Radiol."},{"issue":"1","key":"B5-20260226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1148\/radiol.2501080833","article-title":"Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials","volume":"250","author":"Heinrich","year":"2009","journal-title":"Radiology."},{"issue":"4","key":"B6-20260226","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-104-4-501","article-title":"Risks for renal dysfunction with cardiac angiography","volume":"104","author":"Taliercio","year":"1986","journal-title":"Ann Intern Med."},{"issue":"2","key":"B7-20260226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MNH.0000000000000389","article-title":"Maximum allowable contrast dose and prevention of acute kidney injury following cardiovascular procedures","volume":"27","author":"Aoun","year":"2018","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"1","key":"B8-20260226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.xkme.2020.01.001","article-title":"Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation","volume":"2","author":"Davenport","year":"2020","journal-title":"Kidney Med."},{"issue":"4","key":"B9-20260226","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2214\/AJR.19.21309","article-title":"Contrast-induced acute kidney injury among patients with chronic kidney disease undergoing imaging studies: a meta-analysis","volume":"213","author":"Lee","year":"2019","journal-title":"AJR Am J Roentgenol."},{"issue":"1","key":"B10-20260226","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.12121823","article-title":"Intravenous contrast material\u2013induced nephropathy: causal or coincident phenomenon?","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology."},{"issue":"2","key":"B11-20260226","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B12-20260226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00134-022-06966-w","article-title":"Renal outcomes following intravenous contrast administration in patients with acute kidney injury: a multi-site retrospective propensity-adjusted analysis","volume":"49","author":"Ehmann","year":"2023","journal-title":"Intensive Care Med."},{"issue":"3","key":"B13-20260226","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s00330-023-10059-7","article-title":"Acute and long-term renal effects after iodine contrast media\u2013enhanced computerised tomography in the critically ill\u2014a retrospective bi-centre cohort study","volume":"34","author":"Berglund","year":"2024","journal-title":"Eur Radiol."},{"issue":"8","key":"B14-20260226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/RLI.0b013e3181d77eed","article-title":"Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents","volume":"45","author":"Sendeski","year":"2010","journal-title":"Invest Radiol."},{"issue":"10","key":"B15-20260226","doi-asserted-by":"crossref","first-page":"e23179","DOI":"10.1096\/fj.202301316R","article-title":"Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy","volume":"37","author":"Shi","year":"2023","journal-title":"FASEB J."},{"issue":"3","key":"B16-20260226","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material\u2013induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology."},{"issue":"5","key":"B17-20260226","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med."},{"issue":"7","key":"B18-20260226","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med."},{"issue":"10076","key":"B19-20260226","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet."},{"issue":"9931","key":"B20-20260226","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet."},{"issue":"9","key":"B21-20260226","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\u201cRenalism\u201d: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","author":"Chertow","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B22-20260226","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jcin.2014.05.024","article-title":"Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention the MOZART (minimizing cOntrast utiliZation with IVUS guidance in coRonary angioplasTy) randomized controlled trial","volume":"7","author":"Mariani","year":"2014","journal-title":"JACC Cardiovasc Interv."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:44Z","timestamp":1786478324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001019","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}